Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome
Nutrients · 2024
DOI: 10.3390/nu16121822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Moritz V Warmbrunn und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Insulin Resistance, Metabolic Syndrome, Biomarkers, Proteome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hartstichting, ZonMw, Dutch Diabetes Federation.
Abstract (Originalsprache)
Context/Objective: In order to better understand which metabolic differences are related to insulin resistance in metabolic syndrome (MetSyn), we used hyperinsulinemic–euglycemic (HE) clamps in individuals with MetSyn and related peripheral insulin resistance to circulating biomarkers. Design/Methods: In this cross-sectional study, HE-clamps were performed in treatment-naive men (n = 97) with MetSyn. Subjects were defined as insulin-resistant based on the rate of disappearance (Rd). Machine learning models and conventional statistics were used to identify biomarkers of insulin resistance. Findings were replicated in a cohort with n = 282 obese men and women with (n = 156) and without (n = 126) MetSyn. In addition to this, the relation between biomarkers and adipose tissue was assessed by nuclear magnetic resonance imaging.
Results
Peripheral insulin resistance is marked by changes in proteins related to inflammatory processes such as IL-1 and TNF-receptor and superfamily members. These proteins can distinguish between insulin-resistant and insulin-sensitive individuals (AUC = 0.72 ± 0.10) with MetSyn. These proteins were also associated with IFG, liver fat (rho 0.36, p = 1.79 × 10−9) and visceral adipose tissue (rho = 0.35, p = 6.80 × 10−9). Interestingly, these proteins had the strongest association in the MetSyn subgroup compared to individuals without MetSyn.
Conclusions
MetSyn associated with insulin resistance is characterized by protein changes related to body fat content, insulin signaling and pro-inflammatory processes. These findings provide novel targets for intervention studies and should be the focus of future in vitro and in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal and Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Amsterdam UMC, Cardiovascular Sciences, Amsterdam Cardiovascular Sciences, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Department of Internal Medicine, Radboud University Medical Center, 6525 EP Nijmegen, The Netherlands.
- Department of Endocrinology and Metabolism, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
- Diabetes Center, Department of Endocrniology and Metabolism, Amsterdam UMC, VU University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
ORCID-Profile: Moritz V Warmbrunn, Harsh Bahrar, Leo A B Joosten, Mark Davids, Niels P Riksen
Förderung
- Hartstichting
- ZonMw
- Dutch Diabetes Federation
- Deutsche Forschungsgemeinschaft
- LeDucq
- Netherlands CardioVascular Research Committee (CVON) IN-CONTROL-II) grant from the Dutch Heart Foundation and Dutch Cardiovascular Alliance
- ZonMw Vici grant 2020
- Leducq consortium
Zitieren
APA
Warmbrunn, M. V., Bahrar, H., de Clercq, N. C., Koopen, A. M., de Groot, P. F., Rutten, J., Joosten, L. A. B., Kootte, R. S., Bouter, K. E. C., Ter Horst, K. W., Hartstra, A. V., Serlie, M. J., Soeters, M. R., van Raalte, D. H., Davids, M., Levin, E., Herrema, H., Riksen, N. P., Netea, M. G., …, & Nieuwdorp, M. (2024). Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome. Nutrients. https://doi.org/10.3390/nu16121822
Vancouver
Warmbrunn MV, Bahrar H, de Clercq NC, Koopen AM, de Groot PF, Rutten J, et al. Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome. Nutrients. 2024. doi:10.3390/nu16121822
BibTeX
@article{Warmbrunn2024,
author = {Warmbrunn, Moritz V and Bahrar, Harsh and de Clercq, Nicolien C and Koopen, Annefleur M and de Groot, Pieter F and Rutten, Joost and Joosten, Leo A B and Kootte, Ruud S and Bouter, Kristien E C and Ter Horst, Kasper W and Hartstra, Annick V and Serlie, Mireille J and Soeters, Maarten R and van Raalte, Daniel H and Davids, Mark and Levin, Evgeni and Herrema, Hilde and Riksen, Niels P and Netea, Mihai G and Groen, Albert K and Nieuwdorp, Max},
title = {Novel Proteome Targets Marking Insulin Resistance in Metabolic Syndrome},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16121822}
}
EUVIMED